When the Managers Panic: Why the Smear Campaign Against “MAHA” Is Failing
There is a telltale sign that a political narrative is running out of oxygen: it stops arguing outcomes and starts pathologizing dissent.
That is precisely what we see in a recent Guardian column attacking Robert F. Kennedy Jr. and the broader “Make America Healthy Again” (MAHA) movement. The piece is not, despite its framing, a serious engagement with public health policy. It is a reaction—sharp, contemptuous, and revealing—from a professional-managerial class that senses it is losing narrative control over health, medicine, and the meaning of “science” itself.
Before engaging any of the claims, it is worth stating plainly what the article itself discloses: the author is a member of the Council on Foreign Relations. That does not invalidate her views—but it situates them. The CFR exists to maintain continuity in elite governance across administrations, industries, and crises. When a CFR-affiliated commentator frames a decentralized, populist health reform movement as an “epidemic” to be “stifled,” we are not reading neutral journalism. We are reading institutional alarm.
Ridicule as a Substitute for Argument
The article opens not with data, outcomes, or policy trade-offs, but with mockery. RFK Jr. is cast as a “carnivalesque spectacle,” his personal life dragged in alongside public health decisions. This is not accidental. Ridicule functions as a cognitive shortcut: it conditions the reader to dismiss the subject before evidence is even presented.
This tactic is increasingly common because it is increasingly necessary. A movement rooted in lived experience—rising chronic disease, declining life expectancy, exhausted families, and unaffordable care—cannot be rebutted easily on the merits. So tone does the work instead.
“Misinformation” Without Demonstration
Throughout the piece, the word misinformation appears as a kind of magic spell. Claims are labeled harmful without being examined. Disagreements are moralized rather than analyzed. No attempt is made to distinguish between speculative hypotheses, contested evidence, poor communication, and outright falsehoods.
This is a critical point: science advances through challenge, refinement, and correction. Bureaucracies, by contrast, maintain authority through labeling. When “misinformation” replaces evidentiary debate, it signals not scientific confidence but institutional fragility.
The public understands this intuitively. That is why the label no longer lands the way it once did.
The Strawman Called “MAHA”
The Guardian piece defines MAHA almost entirely through three culture-war flashpoints: vaccines, fluoride, and raw milk. This framing is strategic. It allows a vast and heterogeneous reform impulse to be reduced to a caricature—one that can be easily dismissed as “anti-science.”
But that is not why millions of Americans are disengaging from institutional medicine.
They are doing so because:
chronic disease now defines modern life,
children are getting sicker earlier,
mental health is collapsing,
food quality has deteriorated,
regulatory capture is no longer subtle, and
the healthcare system is structurally rewarded for lifelong management, not resolution.
These are not fringe concerns. They are mainstream realities. And notably, the column avoids them almost entirely.
Counting Bills Is Not Analysis
The article warns ominously of “more than 420 anti-science bills” introduced at the state level. This is quantity used as fear, not quality used as analysis. Legislation varies widely in intent, scope, and impact. Some bills are reckless. Some are corrective. Some are symbolic reactions to prior overreach.
Lumping them together as a contagion mirrors the very behavior the author claims to oppose: the replacement of discernment with labeling.
The Economics the Article Won’t Touch
At one point, the piece concedes—briefly—that MAHA supporters point to financial incentives driving the pharmaceutical and food industries. Then it rushes to a false equivalence: highlighting a raw-milk producer’s projected $32 million in sales as evidence of corruption.
This is rhetorical misdirection.
A $32 million niche business does not shape national health outcomes. A multi-trillion-dollar medical-industrial economy does. Chronic disease is not merely a public health failure; it is an economic pillar. Any movement that seriously threatens to reduce disease prevalence threatens revenue streams that span insurers, manufacturers, hospital systems, and regulatory consultancies.
That is the conflict the article gestures toward—and then carefully avoids exploring.
Infectious Disease Panic as Political Weapon
Another familiar move appears late in the piece: importing the language of infectious disease outbreaks to discredit a chronic-disease reform movement. We are reminded that “a virus knows no political boundaries,” as though this resolves debates about mandates, state authority, or trust.
But chronic disease is not a spillover phenomenon. It is the slow, cumulative result of policy, environment, diet, stress, and incentive structures. Using outbreak rhetoric to shut down broader reform discussions is not epidemiology; it is fear transfer.
The Real Solution, Revealed
Perhaps the most revealing section of the article is its proposed remedy. The answer to declining trust, we are told, is:
coordinated interstate political alliances,
tens of millions of dollars in PAC spending to elect “science-supporting” candidates, and
partnerships with TikTok influencers to improve messaging.
This is not reform. It is brand management.
The author even acknowledges the problem—“intellectual arrogance” accelerates skepticism—without recognizing the contradiction: you cannot message your way out of a legitimacy crisis caused by captured institutions and broken outcomes.
Why This Narrative Is Failing
The article closes by calling RFK Jr. “patient zero” in an “epidemic” of MAHA misinformation and urges efforts to “stifle the spread.”
That language matters. It is the language of containment, not persuasion. It treats political disagreement as disease and public awakening as pathology.
And that is precisely why this style of commentary is losing power.
People are not rejecting science. They are rejecting a system that demands trust while producing decline, that invokes expertise while avoiding accountability, and that labels questions as heresy instead of answering them.
MAHA, whatever one thinks of its leaders or tactics, is not a virus. It is a signal—of a population no longer willing to accept managed sickness as the price of modern life.
The managerial class can continue to sneer, label, and mobilize influencer campaigns. Or it can do the harder work: confront incentives, admit failures, and allow genuine reform.
History suggests that when elites choose the former, they accelerate the very movements they fear.